Liu Z - Search Results

1

Alzheimer's Disease and Cancer: Common Targets.

Yang X, Dai J, Wu C, Liu Z. Yang X, et al. Among authors: liu z. Mini Rev Med Chem. 2023 Nov 21. doi: 10.2174/0113895575263108231031132404. Online ahead of print. Mini Rev Med Chem. 2023. PMID: 38037912

2

Multi-Target Drug Design of Anti-Alzheimer's Disease based on Tacrine.

Tian S, Huang Z, Meng Q, Liu Z. Tian S, et al. Among authors: liu z. Mini Rev Med Chem. 2021;21(15):2039-2064. doi: 10.2174/1389557521666210212151127. Mini Rev Med Chem. 2021. PMID: 33583371 Review.

3

Discovery of the Next-Generation Pan-TRK Kinase Inhibitors for the Treatment of Cancer.

Liu Z, Yu P, Dong L, Wang W, Duan S, Wang B, Gong X, Ye L, Wang H, Tian J. Liu Z, et al. J Med Chem. 2021 Jul 22;64(14):10286-10296. doi: 10.1021/acs.jmedchem.1c00712. Epub 2021 Jul 12. J Med Chem. 2021. PMID: 34253025

4

Advances in Anti-inflammatory Activity, Mechanism and Therapeutic Application of Ursolic Acid.

Luan M, Wang H, Wang J, Zhang X, Zhao F, Liu Z, Meng Q. Luan M, et al. Among authors: liu z. Mini Rev Med Chem. 2022;22(3):422-436. doi: 10.2174/1389557521666210913113522. Mini Rev Med Chem. 2022. PMID: 34517797 Review.

5

N-Benzyl Benzamide Derivatives as Selective Sub-Nanomolar Butyrylcholinesterase Inhibitors for Possible Treatment in Advanced Alzheimer's Disease.

Du C, Wang L, Guan Q, Yang H, Chen T, Liu Y, Li Q, Lyu W, Lu X, Chen Y, Liu Y, Liu H, Feng F, Liu W, Liu Z, Li W, Chen Y, Sun H. Du C, et al. Among authors: liu z, liu y, liu h, liu w. J Med Chem. 2022 Aug 25;65(16):11365-11387. doi: 10.1021/acs.jmedchem.2c00944. Epub 2022 Aug 15. J Med Chem. 2022. PMID: 35969197

6

Synthesis methods of 1,2,3-/1,2,4-triazoles: A review.

Dai J, Tian S, Yang X, Liu Z. Dai J, et al. Among authors: liu z. Front Chem. 2022 Sep 26;10:891484. doi: 10.3389/fchem.2022.891484. eCollection 2022. Front Chem. 2022. PMID: 36226121 Free PMC article. Review.

7

Role of TBK1 Inhibition in Targeted Therapy of Cancer.

Yang X, Liu Z. Yang X, et al. Among authors: liu z. Mini Rev Med Chem. 2024 Jan 16. doi: 10.2174/0113895575271977231115062803. Online ahead of print. Mini Rev Med Chem. 2024. PMID: 38314681

8

Peptide-based and small synthetic molecule inhibitors on PD-1/PD-L1 pathway: A new choice for immunotherapy?

Chen T, Li Q, Liu Z, Chen Y, Feng F, Sun H. Chen T, et al. Among authors: liu z. Eur J Med Chem. 2019 Jan 1;161:378-398. doi: 10.1016/j.ejmech.2018.10.044. Epub 2018 Oct 19. Eur J Med Chem. 2019. PMID: 30384043 Review.

9

STING, a promising target for small molecular immune modulator: A review.

Liu Y, Lu X, Qin N, Qiao Y, Xing S, Liu W, Feng F, Liu Z, Sun H. Liu Y, et al. Among authors: liu z, liu w. Eur J Med Chem. 2021 Feb 5;211:113113. doi: 10.1016/j.ejmech.2020.113113. Epub 2020 Dec 18. Eur J Med Chem. 2021. PMID: 33360799 Review.

10

Design, Synthesis, and Evaluation of Acetylcholinesterase and Butyrylcholinesterase Dual-Target Inhibitors against Alzheimer's Diseases.

Guo Y, Yang H, Huang Z, Tian S, Li Q, Du C, Chen T, Liu Y, Sun H, Liu Z. Guo Y, et al. Among authors: liu z, liu y. Molecules. 2020 Jan 23;25(3):489. doi: 10.3390/molecules25030489. Molecules. 2020. PMID: 31979317 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82,657 results

Search Page